JP2011509290A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011509290A5 JP2011509290A5 JP2010541891A JP2010541891A JP2011509290A5 JP 2011509290 A5 JP2011509290 A5 JP 2011509290A5 JP 2010541891 A JP2010541891 A JP 2010541891A JP 2010541891 A JP2010541891 A JP 2010541891A JP 2011509290 A5 JP2011509290 A5 JP 2011509290A5
- Authority
- JP
- Japan
- Prior art keywords
- pyrazolo
- pyrimidin
- phenyl
- amine
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- -1 3,5-dimethylphenyl group Chemical class 0.000 claims 53
- 150000001875 compounds Chemical class 0.000 claims 31
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 18
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims 18
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims 16
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims 15
- 239000002904 solvent Substances 0.000 claims 12
- 239000000203 mixture Substances 0.000 claims 10
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims 9
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims 9
- 238000000034 method Methods 0.000 claims 9
- 238000010992 reflux Methods 0.000 claims 9
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims 8
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims 8
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 claims 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims 8
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims 8
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims 6
- 125000003118 aryl group Chemical group 0.000 claims 6
- JFDZBHWFFUWGJE-UHFFFAOYSA-N benzonitrile Substances N#CC1=CC=CC=C1 JFDZBHWFFUWGJE-UHFFFAOYSA-N 0.000 claims 6
- 125000000623 heterocyclic group Chemical group 0.000 claims 6
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims 6
- 125000004527 pyrimidin-4-yl group Chemical group N1=CN=C(C=C1)* 0.000 claims 6
- QUKPALAWEPMWOS-UHFFFAOYSA-N 1h-pyrazolo[3,4-d]pyrimidine Chemical class C1=NC=C2C=NNC2=N1 QUKPALAWEPMWOS-UHFFFAOYSA-N 0.000 claims 5
- 229910052783 alkali metal Inorganic materials 0.000 claims 5
- 239000002585 base Substances 0.000 claims 5
- 239000003586 protic polar solvent Substances 0.000 claims 5
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 5
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 4
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 claims 4
- OEICGMPRFOJHKO-UHFFFAOYSA-N 2-(ethoxymethylidene)propanedinitrile Chemical compound CCOC=C(C#N)C#N OEICGMPRFOJHKO-UHFFFAOYSA-N 0.000 claims 4
- MAKQREKUUHPPIS-UHFFFAOYSA-N 5-amino-1-phenyl-1H-pyrazole-4-carbonitrile Chemical compound NC1=C(C#N)C=NN1C1=CC=CC=C1 MAKQREKUUHPPIS-UHFFFAOYSA-N 0.000 claims 4
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 claims 4
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims 4
- 206010028980 Neoplasm Diseases 0.000 claims 4
- 239000002253 acid Substances 0.000 claims 4
- 229910021529 ammonia Inorganic materials 0.000 claims 4
- 239000000010 aprotic solvent Substances 0.000 claims 4
- 201000011510 cancer Diseases 0.000 claims 4
- 201000010099 disease Diseases 0.000 claims 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 4
- 125000001072 heteroaryl group Chemical group 0.000 claims 4
- 230000003463 hyperproliferative effect Effects 0.000 claims 4
- 229910052500 inorganic mineral Inorganic materials 0.000 claims 4
- 239000011707 mineral Substances 0.000 claims 4
- 229910052757 nitrogen Inorganic materials 0.000 claims 4
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 claims 4
- 150000003839 salts Chemical class 0.000 claims 4
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 claims 4
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 claims 4
- 125000004454 (C1-C6) alkoxycarbonyl group Chemical group 0.000 claims 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims 3
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 claims 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims 3
- 125000003282 alkyl amino group Chemical group 0.000 claims 3
- 239000001099 ammonium carbonate Substances 0.000 claims 3
- 235000012501 ammonium carbonate Nutrition 0.000 claims 3
- 239000003795 chemical substances by application Substances 0.000 claims 3
- 125000004093 cyano group Chemical group *C#N 0.000 claims 3
- 229910052739 hydrogen Inorganic materials 0.000 claims 3
- 150000002431 hydrogen Chemical class 0.000 claims 3
- 239000001257 hydrogen Substances 0.000 claims 3
- 238000004519 manufacturing process Methods 0.000 claims 3
- 229910000027 potassium carbonate Inorganic materials 0.000 claims 3
- 229910000029 sodium carbonate Inorganic materials 0.000 claims 3
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 claims 3
- 125000004890 (C1-C6) alkylamino group Chemical group 0.000 claims 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical group N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 2
- KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical compound NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 claims 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims 2
- 241000124008 Mammalia Species 0.000 claims 2
- BXDZOYLPNAIDOC-UHFFFAOYSA-N N-[5-[(5-tert-butyl-1,3-oxazol-2-yl)methylsulfanyl]-1,3-thiazol-2-yl]-1-[2-[2-[2-[2-[2-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]ethoxy]ethoxy]ethoxy]ethylamino]-2-oxoethyl]piperidine-4-carboxamide Chemical compound CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCN(CC(=O)NCCOCCOCCOCCNc4cccc5C(=O)N(C6CCC(=O)NC6=O)C(=O)c45)CC3)s2)o1 BXDZOYLPNAIDOC-UHFFFAOYSA-N 0.000 claims 2
- 150000007513 acids Chemical class 0.000 claims 2
- 125000003342 alkenyl group Chemical group 0.000 claims 2
- 125000000217 alkyl group Chemical group 0.000 claims 2
- 125000000304 alkynyl group Chemical group 0.000 claims 2
- 150000001408 amides Chemical class 0.000 claims 2
- 239000012736 aqueous medium Substances 0.000 claims 2
- 125000004104 aryloxy group Chemical group 0.000 claims 2
- 125000005605 benzo group Chemical group 0.000 claims 2
- 229910052799 carbon Inorganic materials 0.000 claims 2
- 150000004649 carbonic acid derivatives Chemical class 0.000 claims 2
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 claims 2
- 125000005843 halogen group Chemical group 0.000 claims 2
- 208000014829 head and neck neoplasm Diseases 0.000 claims 2
- 125000005553 heteroaryloxy group Chemical group 0.000 claims 2
- 230000007062 hydrolysis Effects 0.000 claims 2
- 238000006460 hydrolysis reaction Methods 0.000 claims 2
- 150000004679 hydroxides Chemical class 0.000 claims 2
- 238000011065 in-situ storage Methods 0.000 claims 2
- CUONGYYJJVDODC-UHFFFAOYSA-N malononitrile Chemical compound N#CCC#N CUONGYYJJVDODC-UHFFFAOYSA-N 0.000 claims 2
- SJBHYUWNPFYYNI-UHFFFAOYSA-N n-(2,3-dihydro-1,4-benzodioxin-6-ylmethyl)-1-(3,5-dimethylphenyl)pyrazolo[3,4-d]pyrimidin-4-amine Chemical compound CC1=CC(C)=CC(N2C3=NC=NC(NCC=4C=C5OCCOC5=CC=4)=C3C=N2)=C1 SJBHYUWNPFYYNI-UHFFFAOYSA-N 0.000 claims 2
- 230000003472 neutralizing effect Effects 0.000 claims 2
- 125000002560 nitrile group Chemical group 0.000 claims 2
- 229910052760 oxygen Inorganic materials 0.000 claims 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 2
- 229940067157 phenylhydrazine Drugs 0.000 claims 2
- 150000004031 phenylhydrazines Chemical class 0.000 claims 2
- UHZYTMXLRWXGPK-UHFFFAOYSA-N phosphorus pentachloride Chemical compound ClP(Cl)(Cl)(Cl)Cl UHZYTMXLRWXGPK-UHFFFAOYSA-N 0.000 claims 2
- FAIAAWCVCHQXDN-UHFFFAOYSA-N phosphorus trichloride Chemical compound ClP(Cl)Cl FAIAAWCVCHQXDN-UHFFFAOYSA-N 0.000 claims 2
- OYRRZWATULMEPF-UHFFFAOYSA-N pyrimidin-4-amine Chemical compound NC1=CC=NC=N1 OYRRZWATULMEPF-UHFFFAOYSA-N 0.000 claims 2
- 235000010288 sodium nitrite Nutrition 0.000 claims 2
- HXJUTPCZVOIRIF-UHFFFAOYSA-N sulfolane Chemical compound O=S1(=O)CCCC1 HXJUTPCZVOIRIF-UHFFFAOYSA-N 0.000 claims 2
- 229910052717 sulfur Inorganic materials 0.000 claims 2
- 125000005296 thioaryloxy group Chemical group 0.000 claims 2
- 125000005404 thioheteroaryloxy group Chemical group 0.000 claims 2
- 125000005270 trialkylamine group Chemical group 0.000 claims 2
- GKASDNZWUGIAMG-UHFFFAOYSA-N triethyl orthoformate Chemical compound CCOC(OCC)OCC GKASDNZWUGIAMG-UHFFFAOYSA-N 0.000 claims 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims 1
- FTNJQNQLEGKTGD-UHFFFAOYSA-N 1,3-benzodioxole Chemical compound C1=CC=C2OCOC2=C1 FTNJQNQLEGKTGD-UHFFFAOYSA-N 0.000 claims 1
- HPARLNRMYDSBNO-UHFFFAOYSA-N 1,4-benzodioxine Chemical compound C1=CC=C2OC=COC2=C1 HPARLNRMYDSBNO-UHFFFAOYSA-N 0.000 claims 1
- YSWUDFATSBPVFL-UHFFFAOYSA-N 1-(3,5-dimethylphenyl)-n-[(3,4,5-trimethoxyphenyl)methyl]pyrazolo[3,4-d]pyrimidin-4-amine Chemical compound COC1=C(OC)C(OC)=CC(CNC=2C=3C=NN(C=3N=CN=2)C=2C=C(C)C=C(C)C=2)=C1 YSWUDFATSBPVFL-UHFFFAOYSA-N 0.000 claims 1
- SQAKOPVOUSLGRS-UHFFFAOYSA-N 1-(3,5-dimethylphenyl)-n-[2-(2-methoxyethoxy)ethyl]pyrazolo[3,4-d]pyrimidin-4-amine Chemical compound N1=CC=2C(NCCOCCOC)=NC=NC=2N1C1=CC(C)=CC(C)=C1 SQAKOPVOUSLGRS-UHFFFAOYSA-N 0.000 claims 1
- STYVEAOALAEULT-UHFFFAOYSA-N 1-(3-iodophenyl)pyrazolo[3,4-d]pyrimidine Chemical class IC1=CC=CC(N2C3=NC=NC=C3C=N2)=C1 STYVEAOALAEULT-UHFFFAOYSA-N 0.000 claims 1
- GETXGBDZZACJPV-UHFFFAOYSA-N 1-(3-methylphenyl)-n-[(3,4,5-trimethoxyphenyl)methyl]pyrazolo[3,4-d]pyrimidin-4-amine Chemical compound COC1=C(OC)C(OC)=CC(CNC=2C=3C=NN(C=3N=CN=2)C=2C=C(C)C=CC=2)=C1 GETXGBDZZACJPV-UHFFFAOYSA-N 0.000 claims 1
- VLVZKHQSYVUBEA-UHFFFAOYSA-N 1-(3-methylphenyl)-n-[[4-(3-morpholin-4-ylpropoxy)phenyl]methyl]pyrazolo[3,4-d]pyrimidin-4-amine Chemical compound CC1=CC=CC(N2C3=NC=NC(NCC=4C=CC(OCCCN5CCOCC5)=CC=4)=C3C=N2)=C1 VLVZKHQSYVUBEA-UHFFFAOYSA-N 0.000 claims 1
- GSILHXSZYLRDCW-UHFFFAOYSA-N 1-(3-methylphenyl)pyrazolo[3,4-d]pyrimidine Chemical class CC1=CC=CC(N2C3=NC=NC=C3C=N2)=C1 GSILHXSZYLRDCW-UHFFFAOYSA-N 0.000 claims 1
- ROEFWOWUWFIFHP-UHFFFAOYSA-N 2-[[1-(3,5-dimethylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]amino]acetic acid Chemical compound CC1=CC(C)=CC(N2C3=NC=NC(NCC(O)=O)=C3C=N2)=C1 ROEFWOWUWFIFHP-UHFFFAOYSA-N 0.000 claims 1
- DTTHGYPBDBANKG-UHFFFAOYSA-N 2-[[1-(3-cyanophenyl)pyrazolo[3,4-d]pyrimidin-4-yl]amino]acetic acid Chemical compound N1=CC=2C(NCC(=O)O)=NC=NC=2N1C1=CC=CC(C#N)=C1 DTTHGYPBDBANKG-UHFFFAOYSA-N 0.000 claims 1
- KDMNJOUCLAIXDH-UHFFFAOYSA-N 2-[[1-(3-methylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]amino]acetic acid Chemical compound CC1=CC=CC(N2C3=NC=NC(NCC(O)=O)=C3C=N2)=C1 KDMNJOUCLAIXDH-UHFFFAOYSA-N 0.000 claims 1
- ZVNYYNAAEVZNDW-UHFFFAOYSA-N 2-phenylpyrazol-3-amine Chemical compound NC1=CC=NN1C1=CC=CC=C1 ZVNYYNAAEVZNDW-UHFFFAOYSA-N 0.000 claims 1
- PNAQLBVTHVBJOU-UHFFFAOYSA-N 3,5-dimethylpyrazolo[3,4-d]pyrimidine Chemical class N1=CN(C)C=C2C(C)=NN=C21 PNAQLBVTHVBJOU-UHFFFAOYSA-N 0.000 claims 1
- PNSVHQUIJWZNRG-UHFFFAOYSA-N 3-[4-[(3,4,5-trimethoxyphenyl)methylamino]pyrazolo[3,4-d]pyrimidin-1-yl]benzonitrile Chemical compound COC1=C(OC)C(OC)=CC(CNC=2C=3C=NN(C=3N=CN=2)C=2C=C(C=CC=2)C#N)=C1 PNSVHQUIJWZNRG-UHFFFAOYSA-N 0.000 claims 1
- BWEHNFAHJYUHNO-UHFFFAOYSA-N 3-[4-[(4-methoxyphenyl)methylamino]pyrazolo[3,4-d]pyrimidin-1-yl]benzonitrile Chemical compound C1=CC(OC)=CC=C1CNC1=NC=NC2=C1C=NN2C1=CC=CC(C#N)=C1 BWEHNFAHJYUHNO-UHFFFAOYSA-N 0.000 claims 1
- OXZQINWSJIVXFQ-UHFFFAOYSA-N 3-[4-[[3,4-bis(2-methoxyethoxy)phenyl]methylamino]pyrazolo[3,4-d]pyrimidin-1-yl]benzonitrile Chemical compound C1=C(OCCOC)C(OCCOC)=CC=C1CNC1=NC=NC2=C1C=NN2C1=CC=CC(C#N)=C1 OXZQINWSJIVXFQ-UHFFFAOYSA-N 0.000 claims 1
- DWRMZQCPYGFIGS-UHFFFAOYSA-N 3-[4-[[4-(3-morpholin-4-ylpropoxy)phenyl]methylamino]pyrazolo[3,4-d]pyrimidin-1-yl]benzonitrile Chemical compound N#CC1=CC=CC(N2C3=NC=NC(NCC=4C=CC(OCCCN5CCOCC5)=CC=4)=C3C=N2)=C1 DWRMZQCPYGFIGS-UHFFFAOYSA-N 0.000 claims 1
- OYZFRHPWEVEJQH-UHFFFAOYSA-N 3-[4-[[4-methoxy-3-(3-morpholin-4-ylpropoxy)phenyl]methylamino]pyrazolo[3,4-d]pyrimidin-1-yl]benzonitrile Chemical compound C1=C(OCCCN2CCOCC2)C(OC)=CC=C1CNC(C=1C=N2)=NC=NC=1N2C1=CC=CC(C#N)=C1 OYZFRHPWEVEJQH-UHFFFAOYSA-N 0.000 claims 1
- 125000006305 3-iodophenyl group Chemical group [H]C1=C([H])C(I)=C([H])C(*)=C1[H] 0.000 claims 1
- WJHAGGMBBWXXCU-UHFFFAOYSA-N 3-pyrazolo[3,4-d]pyrimidin-1-ylbenzonitrile Chemical class N#CC1=CC=CC(N2C3=NC=NC=C3C=N2)=C1 WJHAGGMBBWXXCU-UHFFFAOYSA-N 0.000 claims 1
- YMXQUFUYCADCFL-UHFFFAOYSA-N 4-chloro-1h-pyrazolo[3,4-d]pyrimidine Chemical class ClC1=NC=NC2=C1C=NN2 YMXQUFUYCADCFL-UHFFFAOYSA-N 0.000 claims 1
- ZUCMUUMUEOALJU-UHFFFAOYSA-N 4-chloro-3-phenyl-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1=2C(Cl)=NC=NC=2NN=C1C1=CC=CC=C1 ZUCMUUMUEOALJU-UHFFFAOYSA-N 0.000 claims 1
- UBKSUPKIDNXMMC-UHFFFAOYSA-N 5-amino-1-phenylpyrazole-4-carboxamide Chemical compound NC1=C(C(=O)N)C=NN1C1=CC=CC=C1 UBKSUPKIDNXMMC-UHFFFAOYSA-N 0.000 claims 1
- 206010005003 Bladder cancer Diseases 0.000 claims 1
- 208000003174 Brain Neoplasms Diseases 0.000 claims 1
- 206010006187 Breast cancer Diseases 0.000 claims 1
- 208000026310 Breast neoplasm Diseases 0.000 claims 1
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims 1
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 claims 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 1
- 208000000461 Esophageal Neoplasms Diseases 0.000 claims 1
- 208000008839 Kidney Neoplasms Diseases 0.000 claims 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims 1
- 206010025323 Lymphomas Diseases 0.000 claims 1
- 206010030155 Oesophageal carcinoma Diseases 0.000 claims 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 claims 1
- 206010060862 Prostate cancer Diseases 0.000 claims 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 claims 1
- 206010038389 Renal cancer Diseases 0.000 claims 1
- 208000005718 Stomach Neoplasms Diseases 0.000 claims 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims 1
- 208000024770 Thyroid neoplasm Diseases 0.000 claims 1
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 claims 1
- PARWGYPSBMSXSC-UHFFFAOYSA-N [4-(2-methoxyethoxy)phenyl]methanamine Chemical compound COCCOC1=CC=C(CN)C=C1 PARWGYPSBMSXSC-UHFFFAOYSA-N 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 125000005236 alkanoylamino group Chemical group 0.000 claims 1
- 125000003545 alkoxy group Chemical group 0.000 claims 1
- 150000003973 alkyl amines Chemical class 0.000 claims 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 claims 1
- 125000003368 amide group Chemical group 0.000 claims 1
- 150000001412 amines Chemical class 0.000 claims 1
- 125000002490 anilino group Chemical group [H]N(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 claims 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 1
- DOBRDRYODQBAMW-UHFFFAOYSA-N copper(i) cyanide Chemical compound [Cu+].N#[C-] DOBRDRYODQBAMW-UHFFFAOYSA-N 0.000 claims 1
- GBRBMTNGQBKBQE-UHFFFAOYSA-L copper;diiodide Chemical compound I[Cu]I GBRBMTNGQBKBQE-UHFFFAOYSA-L 0.000 claims 1
- 125000004122 cyclic group Chemical group 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 201000004101 esophageal cancer Diseases 0.000 claims 1
- 206010017758 gastric cancer Diseases 0.000 claims 1
- 229910052736 halogen Inorganic materials 0.000 claims 1
- 150000002367 halogens Chemical class 0.000 claims 1
- 238000010438 heat treatment Methods 0.000 claims 1
- 125000005842 heteroatom Chemical group 0.000 claims 1
- 125000000717 hydrazino group Chemical group [H]N([*])N([H])[H] 0.000 claims 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 1
- 125000002346 iodo group Chemical group I* 0.000 claims 1
- 201000010982 kidney cancer Diseases 0.000 claims 1
- 208000032839 leukemia Diseases 0.000 claims 1
- 201000005202 lung cancer Diseases 0.000 claims 1
- 208000020816 lung neoplasm Diseases 0.000 claims 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 claims 1
- 208000026037 malignant tumor of neck Diseases 0.000 claims 1
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 claims 1
- XERHTFBEABJMAL-UHFFFAOYSA-N n-(1,3-benzodioxol-5-ylmethyl)-1-(3,5-dimethylphenyl)pyrazolo[3,4-d]pyrimidin-4-amine Chemical compound CC1=CC(C)=CC(N2C3=NC=NC(NCC=4C=C5OCOC5=CC=4)=C3C=N2)=C1 XERHTFBEABJMAL-UHFFFAOYSA-N 0.000 claims 1
- IIBPUCIUZPGZFD-UHFFFAOYSA-N n-(1,3-benzodioxol-5-ylmethyl)-1-(3-ethynylphenyl)pyrazolo[3,4-d]pyrimidin-4-amine Chemical compound C#CC1=CC=CC(N2C3=NC=NC(NCC=4C=C5OCOC5=CC=4)=C3C=N2)=C1 IIBPUCIUZPGZFD-UHFFFAOYSA-N 0.000 claims 1
- KEZHXUVPGGBABO-UHFFFAOYSA-N n-(2,3-dihydro-1,4-benzodioxin-6-ylmethyl)-1-(3-methylphenyl)pyrazolo[3,4-d]pyrimidin-4-amine Chemical compound CC1=CC=CC(N2C3=NC=NC(NCC=4C=C5OCCOC5=CC=4)=C3C=N2)=C1 KEZHXUVPGGBABO-UHFFFAOYSA-N 0.000 claims 1
- JUIGKLFOQNJFIC-UHFFFAOYSA-N n-[(3,4-dimethoxyphenyl)methyl]-1-(3,5-dimethylphenyl)pyrazolo[3,4-d]pyrimidin-4-amine Chemical compound C1=C(OC)C(OC)=CC=C1CNC1=NC=NC2=C1C=NN2C1=CC(C)=CC(C)=C1 JUIGKLFOQNJFIC-UHFFFAOYSA-N 0.000 claims 1
- XYFNVSNOCNUOOR-UHFFFAOYSA-N n-[(3,4-dimethoxyphenyl)methyl]-1-(3-methylphenyl)pyrazolo[3,4-d]pyrimidin-4-amine Chemical compound C1=C(OC)C(OC)=CC=C1CNC1=NC=NC2=C1C=NN2C1=CC=CC(C)=C1 XYFNVSNOCNUOOR-UHFFFAOYSA-N 0.000 claims 1
- KSESLOVJGZDCDV-UHFFFAOYSA-N n-[(4-methoxyphenyl)methyl]-1-(3-methylphenyl)pyrazolo[3,4-d]pyrimidin-4-amine Chemical compound C1=CC(OC)=CC=C1CNC1=NC=NC2=C1C=NN2C1=CC=CC(C)=C1 KSESLOVJGZDCDV-UHFFFAOYSA-N 0.000 claims 1
- UXLQRQRZMYFOJQ-UHFFFAOYSA-N n-[2-(2-methoxyethoxy)ethyl]-1-(3-methylphenyl)pyrazolo[3,4-d]pyrimidin-4-amine Chemical compound N1=CC=2C(NCCOCCOC)=NC=NC=2N1C1=CC=CC(C)=C1 UXLQRQRZMYFOJQ-UHFFFAOYSA-N 0.000 claims 1
- QYFVWAXNXLJXPI-UHFFFAOYSA-N n-[[3,4-bis(2-methoxyethoxy)phenyl]methyl]-1-(3,5-dimethylphenyl)pyrazolo[3,4-d]pyrimidin-4-amine Chemical compound C1=C(OCCOC)C(OCCOC)=CC=C1CNC1=NC=NC2=C1C=NN2C1=CC(C)=CC(C)=C1 QYFVWAXNXLJXPI-UHFFFAOYSA-N 0.000 claims 1
- DVQNZXMUTFGQDI-UHFFFAOYSA-N n-[[3,4-bis(2-methoxyethoxy)phenyl]methyl]-1-(3-methylphenyl)pyrazolo[3,4-d]pyrimidin-4-amine Chemical compound C1=C(OCCOC)C(OCCOC)=CC=C1CNC1=NC=NC2=C1C=NN2C1=CC=CC(C)=C1 DVQNZXMUTFGQDI-UHFFFAOYSA-N 0.000 claims 1
- UYWJCYDXLYIFMY-UHFFFAOYSA-N n-[[4-(2-methoxyethoxy)phenyl]methyl]-1-(3-methylphenyl)pyrazolo[3,4-d]pyrimidin-4-amine Chemical compound C1=CC(OCCOC)=CC=C1CNC1=NC=NC2=C1C=NN2C1=CC=CC(C)=C1 UYWJCYDXLYIFMY-UHFFFAOYSA-N 0.000 claims 1
- IJTBHPAXFRYDQY-UHFFFAOYSA-N n-[[4-methoxy-3-(3-morpholin-4-ylpropoxy)phenyl]methyl]-1-(3-methylphenyl)pyrazolo[3,4-d]pyrimidin-4-amine Chemical compound C1=C(OCCCN2CCOCC2)C(OC)=CC=C1CNC(C=1C=N2)=NC=NC=1N2C1=CC=CC(C)=C1 IJTBHPAXFRYDQY-UHFFFAOYSA-N 0.000 claims 1
- PFIIOMYDQZYTJG-UHFFFAOYSA-N n-methyl-2,3-dihydro-1,4-benzodioxin-6-amine Chemical compound O1CCOC2=CC(NC)=CC=C21 PFIIOMYDQZYTJG-UHFFFAOYSA-N 0.000 claims 1
- 150000002829 nitrogen Chemical group 0.000 claims 1
- 239000001301 oxygen Substances 0.000 claims 1
- 201000002528 pancreatic cancer Diseases 0.000 claims 1
- 208000008443 pancreatic carcinoma Diseases 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 claims 1
- JOVOSQBPPZZESK-UHFFFAOYSA-N phenylhydrazine hydrochloride Chemical class Cl.NNC1=CC=CC=C1 JOVOSQBPPZZESK-UHFFFAOYSA-N 0.000 claims 1
- 229940038531 phenylhydrazine hydrochloride Drugs 0.000 claims 1
- 239000007787 solid Substances 0.000 claims 1
- 206010041823 squamous cell carcinoma Diseases 0.000 claims 1
- 201000011549 stomach cancer Diseases 0.000 claims 1
- 125000001424 substituent group Chemical group 0.000 claims 1
- 238000006467 substitution reaction Methods 0.000 claims 1
- 239000011593 sulfur Chemical group 0.000 claims 1
- RAHZWNYVWXNFOC-UHFFFAOYSA-N sulfur dioxide Inorganic materials O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 claims 1
- 201000002510 thyroid cancer Diseases 0.000 claims 1
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 claims 1
- CWMFRHBXRUITQE-UHFFFAOYSA-N trimethylsilylacetylene Chemical group C[Si](C)(C)C#C CWMFRHBXRUITQE-UHFFFAOYSA-N 0.000 claims 1
- 201000005112 urinary bladder cancer Diseases 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN109CH2008 | 2008-01-11 | ||
| PCT/IN2009/000037 WO2009098715A2 (en) | 2008-01-11 | 2009-01-12 | Novel pyrazolo [3, 4 -d] pyrimidine derivatives as anti -cancer agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011509290A JP2011509290A (ja) | 2011-03-24 |
| JP2011509290A5 true JP2011509290A5 (https=) | 2012-10-25 |
Family
ID=40933862
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010541891A Pending JP2011509290A (ja) | 2008-01-11 | 2009-01-12 | 抗癌剤としてのピラゾロ［３，４‐ｄ］ピリミジン誘導体 |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US8349847B2 (https=) |
| EP (1) | EP2247596A2 (https=) |
| JP (1) | JP2011509290A (https=) |
| KR (1) | KR20100116607A (https=) |
| CN (1) | CN101965350A (https=) |
| AP (1) | AP2010005347A0 (https=) |
| AU (1) | AU2009211004C1 (https=) |
| BR (1) | BRPI0906475A2 (https=) |
| CA (1) | CA2711777A1 (https=) |
| CO (1) | CO6382174A2 (https=) |
| EA (1) | EA201070841A1 (https=) |
| GE (1) | GEP20135780B (https=) |
| IL (1) | IL206811A0 (https=) |
| MA (1) | MA32009B1 (https=) |
| MX (1) | MX2010007523A (https=) |
| NZ (1) | NZ586642A (https=) |
| WO (1) | WO2009098715A2 (https=) |
| ZA (1) | ZA201004823B (https=) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104945420A (zh) | 2009-06-29 | 2015-09-30 | 因塞特公司 | 作为pi3k抑制剂的嘧啶酮类 |
| US8680108B2 (en) * | 2009-12-18 | 2014-03-25 | Incyte Corporation | Substituted fused aryl and heteroaryl derivatives as PI3K inhibitors |
| WO2011075643A1 (en) | 2009-12-18 | 2011-06-23 | Incyte Corporation | Substituted heteroaryl fused derivatives as pi3k inhibitors |
| AR081823A1 (es) | 2010-04-14 | 2012-10-24 | Incyte Corp | DERIVADOS FUSIONADOS COMO INHIBIDORES DE PI3Kd |
| US9062055B2 (en) | 2010-06-21 | 2015-06-23 | Incyte Corporation | Fused pyrrole derivatives as PI3K inhibitors |
| EP2655374B1 (en) | 2010-12-20 | 2019-10-23 | Incyte Holdings Corporation | N-(1-(substituted-phenyl)ethyl)-9h-purin-6-amines as pi3k inhibitors |
| US9108984B2 (en) | 2011-03-14 | 2015-08-18 | Incyte Corporation | Substituted diamino-pyrimidine and diamino-pyridine derivatives as PI3K inhibitors |
| WO2012135009A1 (en) | 2011-03-25 | 2012-10-04 | Incyte Corporation | Pyrimidine-4,6-diamine derivatives as pi3k inhibitors |
| KR102507287B1 (ko) | 2011-09-02 | 2023-03-07 | 인사이트 홀딩스 코포레이션 | Ｐｉ３ｋ 억제제로서 헤테로시클릴아민 |
| AR090548A1 (es) | 2012-04-02 | 2014-11-19 | Incyte Corp | Azaheterociclobencilaminas biciclicas como inhibidores de pi3k |
| CN102746309B (zh) * | 2012-07-09 | 2013-06-05 | 四川大学 | 1-N-乙基-4-N-2′-取代酰基肼-1H-吡唑[3,4-d]嘧啶类衍生物及其制备方法和用途 |
| CN102746307B (zh) * | 2012-07-09 | 2013-07-31 | 四川大学 | 1-n-苄基别嘌醇衍生物及其制备方法和用途 |
| CN103965202B (zh) * | 2014-05-21 | 2016-01-20 | 邹宏丽 | 二环稠合杂环化合物、其制备方法及用途 |
| WO2015191677A1 (en) | 2014-06-11 | 2015-12-17 | Incyte Corporation | Bicyclic heteroarylaminoalkyl phenyl derivatives as pi3k inhibitors |
| SI3831833T1 (sl) | 2015-02-27 | 2023-03-31 | Incyte Holdings Corporation | Postopki za pripravo inhibitorja PI3K |
| US9732097B2 (en) | 2015-05-11 | 2017-08-15 | Incyte Corporation | Process for the synthesis of a phosphoinositide 3-kinase inhibitor |
| US9988401B2 (en) | 2015-05-11 | 2018-06-05 | Incyte Corporation | Crystalline forms of a PI3K inhibitor |
| CN106008527B (zh) * | 2016-06-29 | 2018-05-15 | 四川大学华西医院 | 吡唑并[3,4-d]嘧啶衍生物 |
| CN107698596A (zh) * | 2017-11-15 | 2018-02-16 | 双鹤药业（商丘）有限责任公司 | 一种别嘌醇的合成方法 |
| CA3101323A1 (en) | 2018-06-01 | 2019-12-05 | Incyte Corporation | Dosing regimen for the treatment of pi3k related disorders |
| EP4081528A4 (en) * | 2019-12-23 | 2024-03-13 | Sanford Burnham Prebys Medical Discovery Institute | ECTONUCLEOTIDE PYROPHOSPHATASE/PHOSPHODIESTERASE 1 (ENPP1) MODULATORS AND USES THEREOF |
| CN115304607B (zh) * | 2022-07-06 | 2023-06-27 | 华南农业大学 | 吡唑并嘧啶衍生物的制备方法 |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3000688A (en) | 1961-09-19 | Process for vatting of vat dyestuffs | ||
| US3551428A (en) | 1956-02-10 | 1970-12-29 | Ciba Geigy Corp | New 1- (or 2-) substituted 4-mercapto-pyrazolo(3,4-d)pyrimidines |
| JPS5439096A (en) | 1977-08-27 | 1979-03-24 | Lion Dentifrice Co Ltd | 11phenyll1hhpyrazolo*3*44d*pyrimidinee44 carbonitrile |
| US5958930A (en) | 1991-04-08 | 1999-09-28 | Duquesne University Of The Holy Ghost | Pyrrolo pyrimidine and furo pyrimidine derivatives |
| US5877178A (en) | 1991-04-08 | 1999-03-02 | Duquesne University Of The Holy Ghost | Pyrimidine derivatives and methods of making and using these derivatives |
| US5593997A (en) | 1995-05-23 | 1997-01-14 | Pfizer Inc. | 4-aminopyrazolo(3-,4-D)pyrimidine and 4-aminopyrazolo-(3,4-D)pyridine tyrosine kinase inhibitors |
| MX9800215A (es) | 1995-07-06 | 1998-03-31 | Novartis Ag | Pirrolopirimidas y procesos para su preparacion. |
| ATE217873T1 (de) | 1996-01-23 | 2002-06-15 | Novartis Erfind Verwalt Gmbh | Pyrrolopyrimidinen und verfahren zu deren herstellung |
| CH690773A5 (de) | 1996-02-01 | 2001-01-15 | Novartis Ag | Pyrrolo(2,3-d)pyrimide und ihre Verwendung. |
| US6537999B2 (en) | 1996-06-06 | 2003-03-25 | Duquesne University Of The Holy Ghost | Pyrimidine derivatives and methods of making and using these derivatives |
| WO1998007726A1 (en) | 1996-08-23 | 1998-02-26 | Novartis Ag | Substituted pyrrolopyrimidines and processes for their preparation |
| DE19709488A1 (de) | 1997-03-07 | 1998-09-10 | Basf Ag | Verfahren zur N-Alkylierung von Aminen |
| ID24300A (id) | 1997-08-05 | 2000-07-13 | Pfizer Prod Inc | 4-AMINOPIROL(3,2-d)PIRIMIDIN SEBAGAI ANTAGONIS-ANTAGONIS RESEPTOR NEUROPEPTIDA Y |
| US6686366B1 (en) | 1998-06-02 | 2004-02-03 | Osi Pharmaceuticals, Inc. | Compounds specific to adenosine A3 receptor and uses thereof |
| US6423871B1 (en) | 1999-02-26 | 2002-07-23 | University Of South Florida | Efficient synthesis of secondary amines by selective alkylation of primary amines |
| DE60026297T2 (de) | 1999-05-21 | 2006-11-02 | Bristol-Myers Squibb Co. | Pyrrolotriazin kinasehemmer |
| ITMI992711A1 (it) | 1999-12-27 | 2001-06-27 | Novartis Ag | Composti organici |
| WO2001072751A1 (en) | 2000-03-29 | 2001-10-04 | Knoll Gesellschaft Mit Beschraenkter Haftung | Pyrrolopyrimidines as tyrosine kinase inhibitors |
| US6673802B2 (en) | 2000-12-01 | 2004-01-06 | Osi Pharmaceuticals, Inc. | Compounds specific to adenosine A3 receptor and uses thereof |
| AP1893A (en) | 2000-12-01 | 2008-09-23 | Osi Pharm Inc | Compounds specific to adenosine A1, A2A and A3 receptor and uses thereof |
| US6680324B2 (en) | 2000-12-01 | 2004-01-20 | Osi Pharmaceuticals, Inc. | Compounds specific to adenosine A1 receptors and uses thereof |
| DE10060388A1 (de) * | 2000-12-05 | 2002-06-06 | Merck Patent Gmbh | Verwendung von Pyrazolo [4,3-d]pyrimidinen |
| AR035885A1 (es) | 2001-05-14 | 2004-07-21 | Novartis Ag | Derivados de 4-amino-5-fenil-7-ciclobutilpirrolo (2,3-d)pirimidina, un proceso para su preparacion, una composicion farmaceutica y el uso de dichos derivados para la preparacion de una composicion farmaceutica |
| AU2002315389A1 (en) | 2001-06-21 | 2003-01-08 | Ariad Pharmaceuticals, Inc. | Novel pyrazolo-and pyrrolo-pyrimidines and uses thereof |
| GB0115393D0 (en) | 2001-06-23 | 2001-08-15 | Aventis Pharma Ltd | Chemical compounds |
| US7115617B2 (en) | 2001-08-22 | 2006-10-03 | Amgen Inc. | Amino-substituted pyrimidinyl derivatives and methods of use |
| US6939874B2 (en) | 2001-08-22 | 2005-09-06 | Amgen Inc. | Substituted pyrimidinyl derivatives and methods of use |
| ATE323702T1 (de) | 2002-08-06 | 2006-05-15 | Astrazeneca Ab | Kondensierte pyridine und pyrimidine mit tie2 (tek) aktivität |
| US20040138238A1 (en) | 2002-08-08 | 2004-07-15 | Dhanoa Dale S. | Substituted aminopyrimidine compounds as neurokinin antagonists |
-
2009
- 2009-01-12 EP EP09761144A patent/EP2247596A2/en not_active Withdrawn
- 2009-01-12 GE GEAP200911914A patent/GEP20135780B/en unknown
- 2009-01-12 CN CN2009801083051A patent/CN101965350A/zh active Pending
- 2009-01-12 KR KR1020107017777A patent/KR20100116607A/ko not_active Withdrawn
- 2009-01-12 AU AU2009211004A patent/AU2009211004C1/en not_active Ceased
- 2009-01-12 AP AP2010005347A patent/AP2010005347A0/en unknown
- 2009-01-12 US US12/812,405 patent/US8349847B2/en not_active Expired - Fee Related
- 2009-01-12 BR BRPI0906475-3A patent/BRPI0906475A2/pt not_active IP Right Cessation
- 2009-01-12 NZ NZ586642A patent/NZ586642A/en not_active IP Right Cessation
- 2009-01-12 CA CA2711777A patent/CA2711777A1/en not_active Abandoned
- 2009-01-12 JP JP2010541891A patent/JP2011509290A/ja active Pending
- 2009-01-12 MX MX2010007523A patent/MX2010007523A/es not_active Application Discontinuation
- 2009-01-12 EA EA201070841A patent/EA201070841A1/ru unknown
- 2009-01-12 WO PCT/IN2009/000037 patent/WO2009098715A2/en not_active Ceased
-
2010
- 2010-07-05 IL IL206811A patent/IL206811A0/en unknown
- 2010-07-08 ZA ZA2010/04823A patent/ZA201004823B/en unknown
- 2010-07-09 MA MA33007A patent/MA32009B1/fr unknown
- 2010-08-11 CO CO10098749A patent/CO6382174A2/es not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011509290A5 (https=) | ||
| WO2009098715A4 (en) | Novel pyrazolo [3, 4 -d] pyrimidine derivatives as anti -cancer agents | |
| JP5997335B2 (ja) | Ｎ含有複素環式化合物 | |
| ES3058882T3 (en) | Compounds and compositions for modulating egfr mutant kinase activities | |
| KR101362621B1 (ko) | 화합물 | |
| ES2799520T3 (es) | Compuestos de pirazolo[3,4-d]pirimidina o sales de los mismos | |
| KR101737753B1 (ko) | 페닐 아미노 피리미딘 화합물 및 이의 용도 | |
| ES2738573T3 (es) | Sal de compuesto heterocíclico que contiene nitrógeno o cristal del mismo, composición farmacéutica e inhibidor de FLT3 | |
| ES2877678T3 (es) | Método de preparación para un compuesto de pirrolopirimidina quiral | |
| US7312330B2 (en) | Bicycloheteroarylamine compounds as ion channel ligands and uses thereof | |
| US10196365B2 (en) | Quinazoline derivative, preparation method therefor, and pharmaceutical composition and application thereof | |
| JP2007517052A (ja) | 二環式ヘテロ環式ｐ−３８キナーゼ阻害剤 | |
| CA2634018A1 (en) | Pyrimidine derivatives | |
| EP2121634A1 (en) | Pyrimidine-2,4-diamine derivatives and their use as jak2 kinase inhibitors | |
| JP2008546639A (ja) | 縮合複素環式化合物、並びにそれらの組成物及び使用 | |
| WO2012092880A1 (en) | 2,4-DIAMINO-6,7-DIHYDRO-5H-PYRROLO[2,3]PYRIMIDINE DERIVATIVES AS FAK/Pyk2 INHIBITORS | |
| CN107141288B (zh) | 一类吴茱萸碱类化合物及其制备方法与应用 | |
| CA2604284A1 (en) | Protein kinase inhibitors | |
| WO2023096915A1 (en) | Multicyclic compounds | |
| JP2008503443A (ja) | テトラヒドロピリジンで置換されたピロロピリミジン及びピロロピリジンの誘導体 | |
| JP2022534501A (ja) | 三環式化合物 | |
| JP2008524211A5 (https=) | ||
| CN1778797A (zh) | 制备N－(吡咯并[2,3－d]嘧啶－5－基)酰基谷氨酸衍生物的方法及中间体 | |
| ES2278345T3 (es) | Imidazo-pirimidinas y triazolo-pirimidinas: ligandos de receptores de benzodiazepinas. | |
| JP2007506745A5 (https=) |